Oculus Innovative Sciences Introduces Microcyn® Wound Care OTC for U.S. Consumer Market

PETALUMA, Calif. – Oculus Innovative Sciences, Inc. today announced that its Microcyn® Wound Care OTC, a non-irritating pH-balanced wound cleanser, is now available over-the-counter in the United States. Microcyn Wound Care OTC, which has been cleared by the FDA for moistening absorbent wound dressings and cleaning minor cuts, minor burns, superficial abrasions and minor irritations of the skin, is safe to use around the nose, mouth and eyes. Additionally, it is ready to use with no mixing, dilution or rinsing required and can be used directly on the wound or in combination with gauze, sponges or other absorbent wound dressings.

“There has been increasing demand from U.S. consumers for over-the-counter access to the Microcyn technology,” said Hoji Alimi, CEO and founder of Oculus. “Based upon our successful test marketing and positive feedback from U.S. physicians, including those associated with our ongoing product launch into the U.S. podiatry market, we believe Microcyn Wound Care OTC will provide consumers with an exciting and demonstrative wound care alternative.”  

Upon successful completion of the OTC introduction, the company plans to explore additional distribution channels via partners and retailers.

Microcyn Wound Care OTC can be ordered for $20 plus shipping, handling and tax for an eight-ounce bottle by phone at (800) 759-9305 and at www.oculusis.com/us/otc.

Source: Oculus Innovative Sciences